Immuneering.com

Similar sites

immuniweb.com

Category

Computer Security

Global Rank

N/A

Rank in 1 month

10.8K

Estimate Value

N/A

immunize.org

Category

N/A

Global Rank

N/A

Rank in 1 month

26.2K

Estimate Value

N/A

#vaccination

#vaccines

#health

#coalition

#action

immunology.one

Category

N/A

Global Rank

N/A

Rank in 1 month

Estimate Value

N/A

immuniplus.com

Category

N/A

Global Rank

N/A

Rank in 1 month

Estimate Value

N/A

immunizebc.ca

Category

Health

Global Rank

N/A

Rank in 1 month

52.5K

Estimate Value

N/A

evidence-based immunization information and tools for b.c. residents

#surrey memorial hospital

#gofraserhealth

#fraser health jobs

#british columbia

#bc wildfires

#vancouver

#vancouver canada

#stanley park

#vancouver bc

#stanley park vancouver

#health

#vaccines

#hpv vaccine

#flu shot bc

#hepatitis b vaccine

#burnaby health unit

#shingles vaccine

immunobites.com

Category

N/A

Global Rank

N/A

Rank in 1 month

Estimate Value

N/A

immunant.com

Category

N/A

Global Rank

N/A

Rank in 1 month

Estimate Value

N/A

Immunant, Inc

immunitet.org

Category

Health

Global Rank

N/A

Rank in 1 month

1.1K

Estimate Value

N/A

что такое иммунитет? упрощенное представление о том, что иммунитет зависит от чего-то одного, неверно, так как в организме все взаимосвязано.

immuno-complex.instbroker.com

Category

N/A

Global Rank

N/A

Rank in 1 month

Estimate Value

N/A

immunizeelpaso.org

Category

N/A

Global Rank

N/A

Rank in 1 month

Estimate Value

N/A

Sorry. Description is not currently available

#education

#health

#el paso

Malware Scan Info

Macafee Check :

Email address with immuneering.com

Found 1 emails of this domain
1. [email protected]

Recent Searched Sites

Aittuhitzaldiak.eus (13 seconds ago) / ES

Marvelofficial.com (46 seconds ago) / US

Dragonforce.io (41 seconds ago) / US

Musouen.co.jp (6 seconds ago) / JP

Immuneering.com (0 seconds ago) / US

6319o.com (1 seconds ago) / US

5mart5tart.com (1 seconds ago) / US

B-hotel-pisa.ibooked.dk (30 seconds ago) / US

Pixlee.com (10 seconds ago) / US

Frmailing.com (15 seconds ago) / US

Magazine.how-ma.com (24 seconds ago) / US

Cristinaruth.com (32 seconds ago) / US

Road-rail-corp.brandt.ca (4 seconds ago) / CA

Coachloya.com (12 seconds ago) / US

Lia.io (2 mins ago) / US

Oyakcem.mobi (1 mins ago) / US

Arvidija.lt (9 seconds ago) / LT

Bmiministries.com (1 mins ago) / US

Ercanticaret.otocikma.com (1 mins ago) / FR

Mvsavingsbank.com (24 seconds ago) / AU

List of our tools

Emails by domain

Mobile Friendly Check

Page Speed Check

DNS Lookup

Ports Scan

Sites on host

Sitemap Generator

Immuneering.com lookup results from whois.godaddy.com server:

Network

Owner

Abuse

Technical support

Domain Provider	Number Of Domains
godaddy.com	681204
namecheap.com	225421
networksolutions.com	166577
tucows.com	137813
publicdomainregistry.com	87031
whois.godaddy.com	62126
enomdomains.com	57945
cloudflare.com	50903
namesilo.com	48588
gmo.jp	46308
register.com	38833
fastdomain.com	38037
ionos.com	33902
wildwestdomains.com	32100
name.com	32000
net.cn	30701
registrar.amazon.com	30607
dynadot.com	28494
key-systems.net	27144

Host Informations


Host name	93.75.197.35.bc.googleusercontent.com
IP address	35.197.75.93
Location	Mountain View United States
Latitude	37.4043
Longitude	-122.0748
Metro Code	807
Timezone	America/Los_Angeles
Postal	94043

Check all domain's dns records

Port Scanner (IP: 35.197.75.93)

› Ftp: 21

› Ssh: 22

› Telnet: 23

› Smtp: 25

› Dns: 53

› Http: 80

› Pop3: 110

› Portmapper, rpcbind: 111

› Microsoft RPC services: 135

› Netbios: 139

› Imap: 143

› Ldap: 389

› Https: 443

› SMB directly over IP: 445

› Msa-outlook: 587

› IIS, NFS, or listener RFS remote_file_sharing: 1025

› Lotus notes: 1352

› Sql server: 1433

› Point-to-point tunnelling protocol: 1723

› My sql: 3306

› Remote desktop: 3389

› Session Initiation Protocol (SIP): 5060

› Virtual Network Computer display: 5900

› X Window server: 6001

› Webcache: 8080

Spam Check (IP: 35.197.75.93)

› Dnsbl-1.uceprotect.net:

› Dnsbl-2.uceprotect.net:

› Dnsbl-3.uceprotect.net:

› Dnsbl.dronebl.org:

› Dnsbl.sorbs.net:

› Spam.dnsbl.sorbs.net:

› Bl.spamcop.net:

› Recent.dnsbl.sorbs.net:

› All.spamrats.com:

› B.barracudacentral.org:

› Bl.blocklist.de:

› Bl.emailbasura.org:

› Bl.mailspike.org:

› Bl.spamcop.net:

› Cblplus.anti-spam.org.cn:

› Dnsbl.anticaptcha.net:

› Ip.v4bl.org:

› Fnrbl.fast.net:

› Dnsrbl.swinog.ch:

› Mail-abuse.blacklist.jippg.org:

› Singlebl.spamgrouper.com:

› Spam.abuse.ch:

› Spamsources.fabel.dk:

› Virbl.dnsbl.bit.nl:

› Cbl.abuseat.org:

› Dnsbl.justspam.org:

› Zen.spamhaus.org:

See Web Sites Hosted on 35.197.75.93

Fetching Web Sites Hosted

Keyword Suggestion

Immuneering

Immuneering corporation

Immuneering therapeutics

Immuneering stock

Immuneering news

Immuneering san diego

Immuneering azioni

Immuneering biotech

Immuneering stock price

Immuneering 10k

Immuneering careers

Immuneering corp stock

Immuneering corporation stock price

Semrush Domain Overview


Domain Backlinks	4K
Rank	894.1K
Traffic	1.2K
Costs	3 USD

Site Inspections

Websites Listing

We found Websites Listing below when search with immuneering.com on Search Engine

Immuneering Announces Participation in Upcoming Investor …

617-500-8080. [email protected]. Investor Contact: Susan A. Noonan. S.A. Noonan Communications. 917-513-5303. [email protected]. Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting.

Ca.sports.yahoo.com

DA: 19 PA: 50 MOZ Rank: 93

Immuneering Announces Participation in Upcoming Investor

Immuneering’s lead product candidate IMM-1-104 is designed to be a highly selective dual-MEK inhibitor that further disrupts KSR to modulate the signaling dynamics of the MAPK pathway ...

Globenewswire.com

DA: 21 PA: 50 MOZ Rank: 49

Immuneering Corporation | LinkedIn

Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and …

Linkedin.com

DA: 16 PA: 32 MOZ Rank: 50

ir.immuneering.com

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 ...

Ir.immuneering.com

DA: 18 PA: 22 MOZ Rank: 43

Immuneering Announces Pricing of Upsized Initial Public Offering

Immuneering’s lead product candidate, IMM-1-104, is designed to be a highly selective dual-MEK inhibitor that further disrupts KSR …

Finance.yahoo.com

DA: 17 PA: 50 MOZ Rank: 87

Immuneering Announces Participation in Upcoming Investor …

Forward-looking statements contained in this announcement are made as of this date, and Immuneering undertakes no duty to update such information except as required under applicable law. Corporate ...

Fox8.com

DA: 8 PA: 50 MOZ Rank: 45

2022-05-20 | NDAQ:IMRX | Press Release | Immuneering Corporation

Immuneering&CloseCurlyQuote;s lead product candidate IMM-1-104 is designed to be a highly selective dual-MEK inhibitor that further disrupts KSR to modulate the signaling dynamics of the MAPK pathway. Specifically, it is designed to drive deep cyclic inhibition that deprives tumor cells of the sustained proliferative signaling required for rapid growth, while …

Stockhouse.com

DA: 14 PA: 50 MOZ Rank: 44

Immuneering Announces Participation in Upcoming Investor …

Immuneering’s lead product candidate IMM-1-104 is designed to be a highly selective dual-MEK inhibitor that further disrupts KSR to modulate the signaling dynamics of the MAPK pathway. Specifically, it is designed to drive deep cyclic inhibition that deprives tumor cells of the sustained proliferative signaling required for rapid growth, while providing a cadenced, …

Tmcnet.com

DA: 14 PA: 31 MOZ Rank: 52

Immuneering Corp. - Company Profiles - BCIQ

For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the …

Profiles.biocentury.com

DA: 23 PA: 27 MOZ Rank: 58

Immuneering Appoints Rimma Steinhertz, Ph.D., PMP as Vice …

Immuneering’s lead product candidate, IMM-1-104, is designed to be a highly selective dual-MEK inhibitor that further disrupts KSR for the treatment of advanced solid tumors in patients harboring RAS mutant tumors. Additionally, Immuneering has six other oncology programs in the discovery stage that are designed to target either the MAPK or mTOR …

Ca.finance.yahoo.com

DA: 20 PA: 50 MOZ Rank: 90

Immuneering Announces Participation in Citi’s Biopharma …

Biospace.com

DA: 16 PA: 50 MOZ Rank: 40

Immuneering Reports Compelling Preclinical Data on IMM-1-104 …

--Immuneering Corporation, a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular signaling dynamics ...

Nasdaq.com

DA: 14 PA: 50 MOZ Rank: 39

Immuneering Corporation (NASDAQ:IMRX) insiders placed bullish …

Insiders at Immuneering Have Bought Stock Recently Over the last three months, we've seen significant insider buying at Immuneering. In total, insiders bought US$123k worth of shares in that time ...

Finance.yahoo.com

DA: 17 PA: 50 MOZ Rank: 94

Working at Immuneering | Glassdoor

Glassdoor gives you an inside look at what it's like to work at Immuneering, including salaries, reviews, office photos, and more. This is the Immuneering company profile. All content is posted anonymously by employees working at Immuneering.

Glassdoor.com

DA: 17 PA: 50 MOZ Rank: 85

Should You Buy Immuneering (IMRX) Ahead of Earnings?

Immuneering (IMRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Ca.yahoo.com

DA: 12 PA: 50 MOZ Rank: 90

Immuneering Co. (NASDAQ:IMRX) Receives Consensus …

Shares of NASDAQ:IMRX opened at $4.42 on Thursday. Immuneering has a 12-month low of $4.11 and a 12-month high of $33.99. The company’s fifty day moving average is $6.44 and its two-hundred day ...

Defenseworld.net

DA: 20 PA: 50 MOZ Rank: 35

What Kind Of Investors Own Most Of Immuneering Corporation …

Immuneering is a smaller company with a market capitalization of US$279m, so it may still be flying under the radar of many institutional investors. Our …

Nasdaq.com

DA: 14 PA: 50 MOZ Rank: 34

Immuneering Reviews | Glassdoor

1 Immuneering reviews. A free inside look at company reviews and salaries posted anonymously by employees.

Glassdoor.com

DA: 17 PA: 41 MOZ Rank: 75

Immuneering Worker Salaries | Glassdoor

Real salaries of employees at Immuneering, reported anonymously. Immuneering salaries at companies.

Glassdoor.ca

DA: 16 PA: 44 MOZ Rank: 78

IMRX | Immuneering Corp. Annual Income Statement | MarketWatch

Immuneering Corp. Annual stock financials by MarketWatch. View the latest IMRX financial statements, income statements and financial ratios.

Marketwatch.com

DA: 19 PA: 32 MOZ Rank: 70

Domains Expiration Date Updated

Site	Provider	Expiration Date
aautaekwondo.org	cscglobal.com	2 Years, 163 Days
12onyourside.com	gcd.com	262 Days
araby-host.com	publicdomainregistry.com	203 Days
eugdpr.institute	ascio.com	328 Days
vickershydraulic.com	net.cn	271 Days
parkavedrs.net	register.com	195 Days
militarydepotusa.com	godaddy.com	5 Years, 166 Days
pise.pw	publicdomainregistry.com	302 Days

Browser All